A single dose of respiratory syncytial virus vaccine was effective against infections and associated hospitalizations in veterans aged at least 60 years during the 2023-24 season.

Recommendations on the strain composition of influenza virus vaccines for the 2025-2026 US season have been issued by FDA.

ChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...

But the shingles studies published in 2024, along with a host of new papers, add weight to an alternative decades-old ...

Some examples of recombinant nucleic acids frequently used in research include plasmids ... reversion can lead to serious consequences and should not be disregarded. Hence, the risk group of the ...

Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

Seattle, USA-based biotech Curevo Vaccine, which is developing varicella zoster virus (VZV) vaccines with improved tolerability, today announces the closing of a $110 million Series B round to advance ...

Here is everything you need to know about the recent case of human coronavirus case in Kolkata. Understanding the symptoms of ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years ...

Vaccination against shingles may reduce dementia risk, suggesting viral infections play a crucial role in Alzheimer’s disease ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...